Total submissions: 14
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000231657 | SCV000290266 | likely benign | Adams-Oliver syndrome 5 | 2024-01-18 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001580003 | SCV000532655 | likely benign | not provided | 2021-07-28 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 26582918) |
Ambry Genetics | RCV002313950 | SCV000739374 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2018-05-21 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Center for Human Genetics, |
RCV000660158 | SCV000782152 | likely benign | Connective tissue disorder | 2016-11-01 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000231657 | SCV002554478 | likely benign | Adams-Oliver syndrome 5 | 2022-03-15 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV002270044 | SCV002554479 | likely benign | Aortic valve disease 1 | 2022-03-15 | criteria provided, single submitter | clinical testing | |
CHEO Genetics Diagnostic Laboratory, |
RCV002313950 | SCV003838464 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2021-11-02 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV003330599 | SCV004039374 | benign | not specified | 2023-08-24 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001580003 | SCV004162033 | likely benign | not provided | 2023-09-01 | criteria provided, single submitter | clinical testing | NOTCH1: BP4 |
Prevention |
RCV004541443 | SCV004774502 | likely benign | NOTCH1-related disorder | 2019-04-17 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Genome Diagnostics Laboratory, |
RCV001580003 | SCV001809321 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV001580003 | SCV001927738 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV001580003 | SCV001952541 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001580003 | SCV001969667 | likely benign | not provided | no assertion criteria provided | clinical testing |